Annual Report 2018

Lary 1 AB

We improve the quality of life

 

2018 has been a great year for Atos Medical. The strategy “Empowering our end-users” works and our financial results are stronger than ever.

Financial highlights 2018

27%

Total revenue growth

24%

Adjusted laryngectomy
revenue growth

82%

Adjusted Gross margin
excl. depreciation

39%

Adjusted EBITDA margin

Who we are

At Atos Medical, we are committed to giving a voice to people who breathe through a stoma, with design solutions and technologies built on decades of experience and a deep understanding of our users.

Since the introduction of the first Provox® voice prosthesis in 1990, Atos Medical has become the world leader in Laryngectomy Care.

Our commitment and dedicated specialization in this field has allowed us to gain a deep understanding of the needs of our customers. This understanding drives our innovation process and we take pride in continuously bringing innovative solutions to our users.

Over the years we have served the needs of around 100,000 people who have been through a laryngectomy in more than 70 countries. Our comprehensive Laryngectomy Care portfolio which includes a complete range of high-quality Provox voice and pulmonary rehabilitation devices, allows for a personalized combination of solutions for each user.

Atos Medical understands that being the leader in this field comprises more than first-rate product development, and supporting clinical research and education of both professionals and users are integral parts of our business. Our products are featured in over 150 peer-reviewed publications and we support and conduct hundreds of conferences and educational programs every year.

We are proud of our history and our accomplishments and we continue to be excited by learning from our users, enabling us to serve them with the best products, services, and education in Laryngectomy Care.